Association of Thyroid Function and Hormone Sensitivity With Abdominal Fat in Individuals With Overweight and Obesity

Documenti analoghi

• Indirect Comparative Efficacy and Safety of Tirzepatide Versus Oral Semaglutide for the Treatment of Overweight and Obesity
  di: Andreea Ciudin, et al.
  Pubblicazione: (2026)
• Comment on ‘Semaglutide and Tirzepatide Effects on Cardiovascular Outcomes in People With Overweight or Obesity in the Real World ( STEER )’
  di: Chih‐Yuan Wang
  Pubblicazione: (2026)
• Does the Combination of Abdominal Obesity and Vitamin D Deficiency Increase the Risk of Death in Individuals Aged 50 or Older? Evidence From the ELSA Study
  di: Joyce da Silva Milliati, et al.
  Pubblicazione: (2026)
• Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non‐Diabetic Adults: A Meta‐Analysis of Randomised Controlled Trials
  di: Muhammad Hassan Azam, et al.
  Pubblicazione: (2026)
• Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity
  di: Kye‐Yeung Park, et al.
  Pubblicazione: (2026)